AI assistant
Sending…
EQUIFAX INC — Director's Dealing 2021
Dec 7, 2021
30136_dirs_2021-12-07_20de52d0-717f-4cdb-b6c9-3fb6b06629de.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: EQUIFAX INC (EFX)
CIK: 0000033185
Period of Report: 2021-12-03
Reporting Person: Ploder Rodolfo O (Pres-Workforce Solutions)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-12-03 | Common Stock | M | 16196.0000 | $123.4900 | Acquired | 75972.0000 | Direct |
| 2021-12-03 | Common Stock | M | 7007.0000 | $121.3500 | Acquired | 82979.0000 | Direct |
| 2021-12-03 | Common Stock | M | 6469.0000 | $129.9300 | Acquired | 89448.0000 | Direct |
| 2021-12-03 | Common Stock | F | 20581.0000 | $279.2200 | Disposed | 68867.0000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-12-03 | Stock Option/Right to Buy | $129.9300 | M | 6469.0000 | Disposed | 2027-02-16 | Common Stock (6469.0000) | Direct |
| 2021-12-03 | Stock Option/Right to Buy | $121.3500 | M | 7007.0000 | Disposed | 2028-03-05 | Common Stock (7007.0000) | Direct |
| 2021-12-03 | Stock Option/Right to Buy | $123.4900 | M | 16196.0000 | Disposed | 2028-07-27 | Common Stock (16196.0000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 439.0000 | Indirect |
Footnotes
F1: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.
F2: The option vested in three equal annual increments beginning 2/16/2018.
F3: The option vested in three equal annual increments beginning 3/5/2019.
F4: The option vested in three equal annual increments beginning 7/27/2019.
More from EQUIFAX INC
Regulatory Filings
2026
May 13
Major Shareholding Notification
2026
Apr 30
Regulatory Filings
2026
Apr 24
Interim / Quarterly Report
2026
Apr 21
Registration Form
2026
Apr 21
Regulatory Filings
2026
Apr 21
Annual Report
2026
Mar 27
Regulatory Filings
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Mar 27
Major Shareholding Notification
2026
Mar 26